Icon

CAPOTEN (nda018343)- (12.5MG,25MG,37.5MG,50MG,75MG,100MG,150MG)

CAPTOPRIL STRIDES PHARMA
12.5MG,25MG,37.5MG,50MG,75MG,100MG,150MG
Yes No
2010-Aug-24 Expired
None None
None No
CAPOTEN (captopril tablets, USP) is indicated for the treatment of hypertension. CAPOTEN is indicated in the treatment of congestive heart failure usually in combination with diuretics and digitalis. CAPOTEN is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction ≤40% and to reduce the incidence of overt heart failure and subsequent hospitalizations for congestive heart failure in these patients. CAPOTEN is indicated for the treatment of diabetic nephropathy (proteinuria >500 mg/day) in patients with type I insulin-dependent diabetes mellitus and retinopathy. CAPOTEN decreases the rate of progression of renal insufficiency and development of serious adverse clinical outcomes (death or need for renal transplantation or dialysis).
7 0 5
Total Other Developers None
Drugs with Suitability No
12.5MG ** ** - - 5
25MG ** ** - - 5
37.5MG ** ** - - -
50MG ** ** - 5 -
75MG ** ** - - -
100MG ** ** - - 5
150MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******** *** ******** ****** ************** **., ***. *********** ******* ****, ******, ******** ******, ***** (***) ***
****** ***** **** ****** ***** *************** *** *********** ****** *** ** ******, ********** ****, ******** **. **, ******* **** ** ****, **. ******, *****, *****, ****** (***) ***
****** ***** * ******* *********, ***. *********** **** *** ******** ****, **********, *** **** (**) *****, ****** ****** (***) ***
****** ********** **********, *** *********** *** **** ******, *********, *** ****** (**) *****, ****** ****** (***) ***
****** ****** ****** *** ****** ****** ******* *********** *-*\*\*, **** ****, *******, *********** *************, *********** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.